PMMI ProSource – Start Your Search
Check out our packaging and processing solutions finder, PMMI ProSource.

Moderna Nears Trials for HIV Vaccine

After the success of its COVID-19 vaccine, Moderna looks for lightning to strike twice.

A recent Free News article discussed the latest mRNA development from Moderna, maker of one of the main COVID-19 vaccines. Apparently the company has two experimental HIV vaccines in work that are expected to begin clinical trials before the end of the year. The vaccines, Moderna mRNA-1644 and mRNA-1644v2-Core, have both passed phase I testing.